Primary CNS Lymphoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma
Condition: Primary Central Nervous System Lymphoma Intervention: Drug: Penpulimab Sponsor: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.
Condition: Rare Disease With Poor Outcome Intervention: Sponsor: Central Hospital, Nancy, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials

Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma
Condition: Primary Central Nervous System Lymphoma Intervention: Drug: Orelabrutinib Sponsor: Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials

Treatment of Primary CNS Lymphoma ( FTD )
Condition: Primary CNS Lymphoma (PCNSL) Interventions: Drug: HD-MTX-Ara-C regimen; Drug: FTD regimen Sponsors: Mingzhi Zhang; Zhengzhou University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2022 Category: Research Source Type: clinical trials